Epithalon for Sale: 9.64 mg Measured, 10 mg Printed

Epithalon for sale is a page of claims, and the useful question is which of those claims could be contradicted by a document. Most cannot. A photograph of a vial, a promise about shipping and an adjective about quality are not the sort of thing a laboratory report speaks to at all.

Seven fields are different, and one of them is doing far more work than the rest. The batch examined below publishes a measured fill weight, which is the field almost nobody in this market measures, and the measurement came in under the number printed on the label.

Epithalon for sale: seven fields, and what a certificate does to each

The right-hand column is the point of the table. A field is worth reading only if there is something a buyer can do with it, and several of the fields most prominent in listings turn out to have nothing behind them at all.

Six of the seven are ordinary hygiene, and any careful supplier can satisfy them without commissioning a single extra test. The second row is the one that costs money, and it is the one this page is about. A field-by-field version of the same exercise, built around what a lyophilised vial has to declare before a buyer can evaluate it, is in our page on what a lyophilised vial must declare.

The quantity field, where a printed number is not a measurement

A vial sold by the milligram invites an assumption that somebody counted the milligrams. Usually nobody did. Powder is filled to a target weight on a line with a tolerance around it, the label prints the target, and unless a laboratory weighs the contents afterwards the figure on the box is a manufacturing intention rather than a result. That is not deception. It is simply a different kind of statement from the one buyers read it as.

Report KVR-2026-A36FF4, issued by Kovera Labs for Ascension Peptides and certified 23 May 2026 for batch 15-05260628, is the exception. It states the specification as 10 mg with a tolerance of 10 percent either way, which fixes an acceptance band of 9.0 to 11.0 mg, and it reports a measured net content of 9.64 mg. The result is a pass, because it sits inside the band. It is also 0.36 mg below the printed label, which is 3.6 percent of the nominal quantity.

Both facts are true simultaneously and each is worth stating. Nothing was violated: the specification permitted this and the certificate says so. And the vial holds less than the box claims, which is a real thing a buyer paid for and did not receive. Publishing the measurement is how a reader gets to hold both thoughts at once, and a listing that never runs the test lets the reader hold neither. The same test run on a neighbouring compound at the same storefront produced the opposite result, a vial assaying 12.29 mg against a 10 mg label, and we worked through that case in our page on a quantity result that contradicts the listing. Over and under are both news, and only a supplier who weighs can deliver either.

What 9.64 mg costs, and what the tolerance permits at its edge

The arithmetic is short and worth doing twice, because publishing only the flattering half is how per-milligram figures get quoted across this market. At the vendor disclosed above the vial lists at $50.00 and falls to $25.00 with the code. On the label basis that is $2.50 per milligram. On the weight the certificate actually measured it is $25.00 divided by 9.64, which is $2.59 per milligram, about 3.7 percent more than the headline figure. At list price the same pair reads $5.00 and $5.19.

The more useful number is the one at the edge of the specification. A tolerance of 10 percent either way permits a fill as low as 9.0 mg, and at $25.00 that would be $2.78 per milligram. Nothing suggests this batch is anywhere near that floor, and that is the point: the floor is what the buyer agreed to when they accepted a nominal label, and only a supplier that measures ever tells them where within the band they landed. Quantity tiers of three, five or ten vials take 3, 5 or 10 percent off the list price, and free carriage begins at $250. Whether a tier reduction combines with the code is undocumented anywhere we could verify, so treat them as separate mechanisms rather than assuming they stack.

The testing scope field, and the gap between coverage and depth

Scope is the field that separates suppliers, and reading it properly means counting lines rather than trusting adjectives. Batch 15-05260628 carries purity at 99.312 percent against a written specification of not less than 98 percent, identity confirmed by LC-MS, the measured net content, an endotoxin safety screen against a limit of 0.5 EU/mL, a microbial sterility screen returning no growth, and a heavy metals block covering arsenic, cadmium, lead and mercury. As coverage that is broad. Most certificates in research peptide supply stop at the first line.

Depth is a separate axis and this document is thin on it. Only purity and net content are reported as measured values. Identity is the word Epithalon returned against a reference standard also given as Epithalon, with no expected mass, no measured mass and no spectrum, so the line is a conclusion rather than something a reader can re-examine. The endotoxin result is the word PASS rather than a concentration, and no method is named, where a fuller report would cite USP Chapter 85 and print a figure alongside its positive and negative controls. The metals are each recorded as negative with no detection limit stated, and negative below an unstated limit is a weaker claim than a concentration below a printed one.

Worth knowing why those two microbiological lines are on the page at all. Purity by HPLC at 214 nm cannot see them: endotoxin does not register meaningfully at that wavelength, viable organisms are not chromatographic peaks, and residual metals are invisible to the method entirely. They are separate commissioned tests with separate consumables, which is the honest reason a better documented vial is not automatically the cheapest one. The related question of a listing quietly omitting the grade of the material it sells is handled in our page on the grade line a repackager omits.

The storage field, which no laboratory can vouch for

Storage is the one field in the table with no analytical backstop, and it is worth reading precisely because of that. A certificate describes material at the moment it was analysed. It does not travel with the parcel, does not record the temperature of a warehouse in July, and does not know how long the vial sat somewhere between the analysis date and dispatch. The gap between 23 May 2026 and the day a box arrives is uncovered by any document on the page.

What the format itself tells you is still useful. A sealed lyophilised powder is the stable presentation of a peptide, which is exactly why it is the presentation sold: water is the agent of most of the degradation, and removing it buys shelf life that a solution does not have. The report for this batch records the form as lyophilized powder along with a red cap and silver crimp, so the description on the listing and the description on the certificate can be compared, which is a smaller check than an assay and still a check. A listing that gives storage conditions contradicting its own stated format has told you something about how carefully it was written, and a listing silent on storage has left the buyer to guess at the one variable the laboratory never measured.

The claims no listing and no certificate can settle

Listings for this compound sell an idea rather than a powder, and the idea is longevity. What sits behind it is a body of animal, cell and in vitro work, much of it from one Russian group, including a 2017 report identifying the AEDG peptide within a pineal gland polypeptide complex. Those are claims with authors and citations attached rather than settled human results, and a search of ClinicalTrials.gov returns no registered study with epitalon, epithalon or AEDG peptide as an intervention.

FDA’s written position is the clearest summary available. Compounded drugs containing epitalon may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, the agency has not identified safety-related information regarding epitalon for the proposed route of administration, and it therefore lacks sufficient information to know whether the drug would cause harm if administered to humans. That is a statement about an empty file rather than about a discovered hazard, and no listing field fills it. A certificate that weighs the powder tells you what you are buying. It does not tell you what buying it does.